Why Meridian Bioscience Stock Shot Up Nearly 13% Today

Meridian Bioscience (NASDAQ: VIVO) was a healthcare sector standout on Wednesday. Since any participation in the fight against the coronavirus is welcome, investors were pleased with the company's announcement that it is supplying reagents for peer diagnostics company QuantuMDx on the latter's most-recent COVID-19 test. 

Image source: Getty Images.

Meridian has garnered attention lately because one of its reagents is being used in a number of different tests for the coronavirus.

Continue reading

Source Fool.com